Trial · NCT04611373
Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC
NCT04611373, Phase 3, Unknown, The First Affiliated Hospital of Zhengzhou University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC. Trials, record NCT04611373. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04611373
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC
- NCT number
- NCT04611373
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 50 participants, estimated
- Lead sponsor
- The First Affiliated Hospital of Zhengzhou University
- Conditions
- HCC
- Interventions
- Acetazolamide Levamisole
- First posted
- 2020-11-02
- Last updated
- 2020-11-02
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Progression-free Survival | 24 months | Time from start of treatment until the first documented event of symptomatic progression or death |
| Secondary | Overall Surviva | 48 months | ime from start of treatment to death from any cause, or last known date of survival |
| Other | Disease Control Rate(DCR) | 28 days | the percentage of patients with advanced or metastatic cancer who have achieved complete response, partial response and stable disease |
| Other | Objective Response Rate(ORR) | 28 days | Proportion of patients with reduction in tumor burden of a predefined amount |
| Other | The change of AFP biomarker | 28 days | Concentration of AFP biomarker change in tumor markers |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04611373
GET https://conductscience.org/api/trials/v1/NCT04611373/registered